Skip to content
Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
mars 2013

8th Workshop, Barcelona: “Impact of the EU Paediatric Regulation on Orphan Drug Development”

8th Workshop of the Eurordis Round Table of Companies:

“Impact of the EU Paediatric Regulation on Orphan Drug Development”


June 20th, 2008

Barcelona, Spain

Fabrizia Bignami

One year after the adoption of the EU Paediatric Regulation, this workshop was an opportunity to learn how the regulatory professionals interpret and implement it in practice. In particular, how setting up a paediatric investigation plan links up with the various phases of orphan drug development (designation, protocol assistance, marketing authorisation). The afternoon discussion clarified the distinctive nature of the development of medicines for use in children and how to facilitate it.

Participants: 53

Key feature: first time that the orphan drug community analysed the benefits of the newly implemented paediatric regulation.


Concept Paper 


For ERTC Members only, this document is password protected. If you want to become a member, find out more here or contact Anne-Mary Bodin, Operations Assistant.